|
|
|
|
Vol. 57, Issue 6, 1243-1248, June 2000
Department of Chemistry, Swarthmore College, Swarthmore,
Pennsylvania (D.K., H.G., R.K.P., J.G.V.); Department of Pharmacology,
University of California at San Diego, La Jolla, California (N.A.H.,
P.T.); and Departments of Neurobiology (I.S.) and Structural Biology
(J.L.S.), Weizmann Institute of Science, Rehovot, Israel
Acetylcholinesterase (AChE), a serine hydrolase, is potentially
susceptible to inactivation by phenylmethylsulfonyl fluoride (PMSF) and
benzenesulfonyl fluoride (BSF). Although BSF inhibits both mouse and
Torpedo californica AChE, PMSF does not react measurably with the T. californica enzyme. To
understand the residue changes responsible for the change in
reactivity, we studied the inactivation of wild-type T.
californica and mouse AChE and mutants of both by BSF and PMSF
both in the presence and absence of substrate. The enzymes investigated
were wild-type mouse AChE, wild-type T. californica
AChE, wild-type mouse butyrylcholinesterase, mouse Y330F, Y330A, F288L,
and F290I, and the double mutant T. californica F288L/F290V (all mutants given T. californica
numbering). Inactivation rate constants for T.
californica AChE confirmed previous reports that this enzyme is
not inactivated by PMSF. Wild-type mouse AChE and mouse mutants Y330F
and Y330A all had similar inactivation rate constants with PMSF,
implying that the difference between mouse and T.
californica AChE at position 330 is not responsible for their
differing PMSF sensitivities. In addition, butyrylcholinesterase and
mouse AChE mutants F288L and F290I had increased rate constants (~14
fold) over those of wild-type mouse AChE, indicating that these
residues may be responsible for the increased sensitivity to
inactivation by PMSF of butyrylcholinesterase. The double mutant T. californica AChE F288L/F290V had a rate constant
nearly identical with the rate constant for the F288L and F290I mouse
mutant AChEs, representing an increase of ~4000-fold over the
T. californica wild-type enzyme. It remains unclear why
these two positions have more importance for T.
californica AChE than for mouse AChE.
This article has been cited by other articles:
![]() |
S. Blech, T. Ebner, E. Ludwig-Schwellinger, J. Stangier, and W. Roth The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans Drug Metab. Dispos., February 1, 2008; 36(2): 386 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Groner, Y. Ashani, D. Schorer-Apelbaum, J. Sterling, Y. Herzig, and M. Weinstock The Kinetics of Inhibition of Human Acetylcholinesterase and Butyrylcholinesterase by Two Series of Novel Carbamates Mol. Pharmacol., June 1, 2007; 71(6): 1610 - 1617. [Abstract] [Full Text] [PDF] |
||||